The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel

The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel

<p>Abstract</p> <p>Background</p> <p>Drinking water contaminated with inorganic arsenic is associated with increased risk for different types of cancer. Paradoxically, arsenic trioxide can also be used to induce remission in patients with acute promyelocytic leukemia (A...

Full description

Bibliographic Details
Main Authors:	Liu Qian, Zhang Hao, Smeester Lisa, Zou Fei, Kesic Matt, Jaspers Ilona, Pi Jingbo, Fry Rebecca C
Format:	Article
Language:	English
Published:	BMC 2010-08-01
Series:	BMC Medical Genomics
Online Access:	http://www.biomedcentral.com/1755-8794/3/37

Similar Items

Global Proteome Analysis of the NCI-60 Cell Line Panel
by: Amin Moghaddas Gholami, et al.
Published: (2013-08-01)

Tetramethylpyrazine potentiates arsenic trioxide activity against HL-60 cell lines
by: Yuni Wu, et al.
Published: (2012-03-01)

Tetramethylpyrazine potentiates arsenic trioxide activity against HL-60 cell lines
by: Yuni Wu, et al.
Published: (2012-03-01)

Arsenic Trioxide: Pharmacological Applications
by: German Madrigal Redondo, et al.
Published: (2023-04-01)

Pharmacogenomics of in vitro response of the NCI-60 cancer cell line panel to Indian natural products
by: Hari Sankaran, et al.
Published: (2022-05-01)

Arsenic Trioxide and Venetoclax Synergize against AML Progenitors by ROS Induction and Inhibition of Nrf2 Activation
by: Dinh Hoa Hoang, et al.
Published: (2022-06-01)

On the Best Way to Cluster NCI-60 Molecules
by: Saiveth Hernández-Hernández, et al.
Published: (2023-03-01)

Basic Mechanisms of Arsenic Trioxide (ATO)-Induced Apoptosis in Human Leukemia (HL-60) Cells
by: Yedjou Clement, et al.
Published: (2010-08-01)

Response to arsenic trioxide in dental treatment
by: Chen Gin
Published: (2013-06-01)

Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy
by: Simon Heumos, et al.
Published: (2022-10-01)

Arsenic trioxide as an inducer of immunogenic cell death
by: Oliver Kepp, et al.
Published: (2023-12-01)

In silico mechanisms of arsenic trioxide-induced cardiotoxicity
by: Yacong Li, et al.
Published: (2022-12-01)

Unlocking the Molecular Secrets of Antifolate Drug Resistance: A Multi-Omics Investigation of the NCI-60 Cell Line Panel
by: Blake R. Rushing
Published: (2023-09-01)

Antiproliferative Activity Predictor: A New Reliable In Silico Tool for Drug Response Prediction against NCI60 Panel
by: Annamaria Martorana, et al.
Published: (2022-11-01)

Expression of microRNAs in the NCI-60 cancer cell-lines.
by: Santosh K Patnaik, et al.
Published: (2012-01-01)

Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines
by: Tiannan Guo, et al.
Published: (2019-11-01)

An integrated analysis of molecular aberrations in NCI-60 cell lines
by: Yeang Chen-Hsiang
Published: (2010-10-01)

Based on Activation of p62-Keap1-Nrf2 Pathway, Hesperidin Protects Arsenic-Trioxide-Induced Cardiotoxicity in Mice
by: Yuxin Jia, et al.
Published: (2021-10-01)

Comparative genomic analyses identify common molecular pathways modulated upon exposure to low doses of arsenic and cadmium
by: Fry Rebecca C, et al.
Published: (2011-04-01)

Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide
by: Kuo Hsing-Chun, et al.
Published: (2008-02-01)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
by: Kamran Alimoghaddam
Published: (2014-09-01)

Arsenic trioxide sensitizes glioblastoma to a myc inhibitor.
by: Yayoi Yoshimura, et al.
Published: (2015-01-01)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
by: Peng Zhang
Published: (2017-01-01)

Modulation of Cellular Response to Arsenic Trioxide Toxicity by Resveratrol
by: Bodhisattwa Mondal, et al.
Published: (2018-05-01)

Magnesium Isoglycyrrhizinate Alleviates Arsenic Trioxide-Induced Cardiotoxicity: Contribution of Nrf2 and TLR4/NF-κB Signaling Pathway
by: Zheng B, et al.
Published: (2021-02-01)

Proteins associated with the doubling time of the NCI-60 cancer cell lines
by: Michael Polymenis
Published: (2017-08-01)

HLA class I and II genotype of the NCI-60 cell lines
by: Morse Herbert C, et al.
Published: (2005-03-01)

NCI-60 whole exome sequencing and pharmacological CellMiner analyses.
by: William C Reinhold, et al.
Published: (2014-01-01)

The effect of Nullomer-derived peptides 9R, 9S1R and 124R on the NCI-60 panel and normal cell lines
by: Abdelkrim Alileche, et al.
Published: (2017-08-01)

Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer.
by: Kira Philipsen Prahm, et al.
Published: (2017-01-01)

Hesperidin attenuates arsenic trioxide-induced cardiac toxicity in rats
by: Gayatri Khuntia, et al.
Published: (2023-01-01)

PML-RARA mutations confer varying arsenic trioxide resistance
by: Dong-Mei Bai, et al.
Published: (2016-12-01)

Treatment of new cases of Acute Promyelocytic Leukemia With Arsenic Trioxide
by: Ardeshir Ghavamzadeh, et al.
Published: (2005-03-01)

Treatment of new cases of Acute Promyelocytic Leukemia With Arsenic Trioxide
by: Ardeshir Ghavamzadeh1, et al.
Published: (2005-06-01)

Evaluation of chronic toxicity of Kushta Sammulfar (calx of Arsenic trioxide)
by: Athar Parvez Ansari, et al.
Published: (2013-06-01)

Use of Arsenic Trioxide as an Antivascular and Thermosensitizing Agent in Solid Tumors
by: Robert J. Griffin, et al.
Published: (2000-01-01)

Cytotoxicity patterns of arsenic trioxide exposure on HaCaT keratinocytes
by: Udensi UK, et al.
Published: (2011-12-01)

Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
by: Sun Ramon C, et al.
Published: (2011-11-01)

Factors determining sensitivity and resistance of tumor cells to arsenic trioxide.
by: Serkan Sertel, et al.
Published: (2012-01-01)

Correction: Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor.
by: Yayoi Yoshimura, et al.
Published: (2016-01-01)